OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
34774056

P&K Skin Research Center Co Ltd

Business Support ServicesVerified

Capital Structure and Liquidity P&K Skin Research Center Co Ltd maintains a strong liquidity position with a current ratio of 9.08, indicating ample short-term assets to cover liabilities. The company holds KRW 3,968,374,460 in cash and equivalents, and its total liabilities of KRW 5,880,882,920 are significantly lower than total equity of KRW 80,643,472,070. The debt-to-equity ratio of 0.01 suggests minimal leverage, with long-term debt at KRW 1,053,783,370. ### Profitability and Returns The company generates a return on equity (ROE) of 5.81% and a return on assets (ROA) of 5.42%, both above the typical thresholds for profitability in the Business Support Services industry. Operating income of KRW 3,892,634,920 and net income of KRW 4,685,339,620 reflect strong operational efficiency. Gross profit of KRW 10,711,898,330 supports a healthy margin structure. ### Segments and Geographic Exposure The company operates as a single entity focused on skin testing and product evaluation services in Korea. Revenue concentration is entirely domestic, with no disclosed international operations or segment breakdowns. This geographic focus may limit diversification but aligns with its core market. ### Growth Trajectory While no explicit growth projections are provided, the company's strong operating cash flow of KRW 6,680,889,580 and free cash flow of KRW 4,176,393,110 suggest capacity for reinvestment or expansion. Capital expenditures of -KRW 1,503,981,140 indicate a net reduction in fixed assets, potentially reflecting asset optimization or maintenance. ### Risk Factors Liquidity risk is assessed as low, with no immediate filing-based flags detected. Dilution risk is also low, with no signs of near-term share issuance or pressure from convertible instruments. The company's minimal debt and strong equity position reduce financial risk exposure. ### Recent Events No recent filings, transcripts, or events are disclosed in the provided data. The company appears to maintain a stable and transparent financial profile without material disclosures of operational or strategic changes.

30-day price · 347740+5.00 (+0.2%)
Low$2060.00High$2635.00Close$2125.00As of21 May, 00:00 UTC
Profile
CompanyP&K Skin Research Center Co Ltd
Ticker347740.KQ
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryBusiness Support Services
AI analysis

Business. P&K Skin Research Center Co Ltd provides human application testing and scientific evaluation services for cosmetics, cosmeceuticals, health foods, and related products in Korea.

Classification. The company is classified under Business Support Services (Industrial & Commercial Services sector) with 92% confidence, aligning with its skin testing and product evaluation services.

### Capital Structure and Liquidity P&K Skin Research Center Co Ltd maintains a strong liquidity position with a current ratio of 9.08, indicating ample short-term assets to cover liabilities. The company holds KRW 3,968,374,460 in cash and equivalents, and its total liabilities of KRW 5,880,882,920 are significantly lower than total equity of KRW 80,643,472,070. The debt-to-equity ratio of 0.01 suggests minimal leverage, with long-term debt at KRW 1,053,783,370. ### Profitability and Returns The company generates a return on equity (ROE) of 5.81% and a return on assets (ROA) of 5.42%, both above the typical thresholds for profitability in the Business Support Services industry. Operating income of KRW 3,892,634,920 and net income of KRW 4,685,339,620 reflect strong operational efficiency. Gross profit of KRW 10,711,898,330 supports a healthy margin structure. ### Segments and Geographic Exposure The company operates as a single entity focused on skin testing and product evaluation services in Korea. Revenue concentration is entirely domestic, with no disclosed international operations or segment breakdowns. This geographic focus may limit diversification but aligns with its core market. ### Growth Trajectory While no explicit growth projections are provided, the company's strong operating cash flow of KRW 6,680,889,580 and free cash flow of KRW 4,176,393,110 suggest capacity for reinvestment or expansion. Capital expenditures of -KRW 1,503,981,140 indicate a net reduction in fixed assets, potentially reflecting asset optimization or maintenance. ### Risk Factors Liquidity risk is assessed as low, with no immediate filing-based flags detected. Dilution risk is also low, with no signs of near-term share issuance or pressure from convertible instruments. The company's minimal debt and strong equity position reduce financial risk exposure. ### Recent Events No recent filings, transcripts, or events are disclosed in the provided data. The company appears to maintain a stable and transparent financial profile without material disclosures of operational or strategic changes.
Key takeaways
  • Strong liquidity and minimal leverage support financial stability.
  • High ROE and ROA indicate efficient use of capital and assets.
  • Domestic focus may limit diversification but aligns with core competencies.
  • Free cash flow and operating cash flow suggest reinvestment potential.
  • Low dilution and liquidity risk reduce downside exposure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$22.78B
Gross profit$10.71B
Operating income$3.89B
Net income$4.69B
R&D
SG&A
D&A
SBC
Operating cash flow$6.68B
CapEx-$1.50B
Free cash flow$4.18B
Total assets$86.52B
Total liabilities$5.88B
Total equity$80.64B
Cash & equivalents$3.97B
Long-term debt$1.05B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$22.78B$3.89B$4.69B$4.18B
FY-1$17.85B$2.58B$5.82B$6.21B
FY-2$14.84B$1.38B$4.81B$4.00B
FY-3$17.96B$5.64B$7.13B$6.35B
FY-4$17.49B$6.46B$7.29B$5.74B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$86.52B$80.64B$3.97B
FY-1$82.04B$76.94B$6.46B
FY-2$77.41B$74.20B$9.80B
FY-3$74.54B$70.81B$4.98B
FY-4$67.09B$63.07B$1.51B
PeriodOCFCapExFCFSBC
FY0$6.68B-$1.50B$4.18B
FY-1$9.03B-$622.1M$6.21B
FY-2$5.55B-$1.56B$4.00B
FY-3$7.51B-$1.36B$6.35B
FY-4$7.70B-$2.81B$5.74B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$5.78B$702.3M-$876.9M-$458.3M
FQ-1$5.05B$451.8M$1.59B$1.82B
FQ-2$5.49B$827.6M$1.61B$1.54B
FQ-3$6.46B$1.91B$2.36B$2.25B
FQ-4$5.13B$739.7M$1.08B$1.19B
FQ-5$4.72B$730.9M$2.34B$2.61B
FQ-6$3.82B$457.8M$1.08B$1.44B
FQ-7$4.19B$654.0M$1.31B$1.68B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$86.52B$80.64B$3.97B
FQ-1$85.87B$81.52B$4.66B
FQ-2$84.69B$79.93B$2.28B
FQ-3$83.88B$78.31B$2.17B
FQ-4$82.04B$76.94B$6.46B
FQ-5$80.44B$75.85B$7.78B
FQ-6$76.83B$73.51B$4.65B
FQ-7$76.88B$73.06B$8.06B
PeriodOCFCapExFCFSBC
FQ0$6.68B-$1.50B-$458.3M
FQ-1$4.78B-$1.42B$1.82B
FQ-2$3.08B-$1.14B$1.54B
FQ-3$1.35B-$569.9M$2.25B
FQ-4$9.03B-$622.1M$1.19B
FQ-5$6.60B-$281.5M$2.61B
FQ-6$4.05B-$127.6M$1.44B
FQ-7$2.09B-$63.5M$1.68B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$80.64B
Net cash$2.91B
Current ratio9.1
Debt/Equity0.0
ROA5.4%
ROE5.8%
Cash conversion1.4%
CapEx/Revenue-6.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Industrial Services · cohort 6 companies
Metric347740Activity
Op margin17.1%11.2% medp25 7.1% · p75 18.5%above median
Net margin20.6%13.8% medp25 13.8% · p75 13.8%top quartile
Gross margin47.0%94.7% medp25 62.9% · p75 126.4%bottom quartile
R&D / revenue6.0% medp25 6.0% · p75 6.0%
CapEx / revenue-6.6%6.7% medp25 4.4% · p75 7.4%bottom quartile
Debt / equity1.0%136.7% medp25 101.5% · p75 217.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 01:35 UTC#8724833e
Source: analysis-pipeline (hybrid)Generated: 2026-05-12 01:38 UTCJob: 68180194